Industry reports
Editor highlights

Publication dates

data types

Estradiol Market and Forecasts, April 2014

You might be interested in: drug, anti-infective, breast cancer, more »


 
1-10 of 83 reports for Estradiol

Global Drug and Medication Sector

  • Industry report
  • June 2013
  • 30 pages

... Of estradiol + progesterone and lower-dose bioidentical progesterone set to begin pivotal phase 3 clinical trials (1) phast prescription monthly by source healthcare analytics. (2) Estimates per: dr. Loyd ...

U.S. Drug and Medication Industry

  • Industry report
  • June 2013
  • 30 pages

... Design combination of estradiol + progesterone rld = reference listed drug api = active pharmaceutical ingredient converted (api) from solid / crystalline to a new liquid drug form estrace (rld ...

U.S. Hormone Sector Brief

  • Industry report
  • January 2012
  • 27 pages

... Such as estradiol or its esters (i.E., estradiol benzoate), which successfully regulate oestrus in cattle, has also led to important improvements and financial gain in stock farming (cavalieri et al., 2005; Mart ...

Hormone Sector in Europe

  • Industry report
  • July 2012
  • 27 pages

... Endometriosis dienogest 2mg + ethinyl estradiol 0.03Mg valette oral contraceptive levonorgestrel 0.03 Mg microlut oral contraceptive (for nursing mothers) levonorgestrel 0.75Mg next choice emergency ...

Estrogen Business in The United States and Canada

  • Industry report
  • January 2012
  • 12 pages
  • by Corporation

... Similar to estradiol and, as such, can bind to ers to induce estrogen-like effects [64, 65]. Exposure to exogenous estrogens during late gestation has the potential to activate the negative feedback loop ...

Drug and Medication Sector in The United States

  • Industry report
  • May 2013
  • 32 pages

... Ethynyl estradiol 10 0.5 Birth control pill 17 beta-estradiol 5 0.5 Natural female bisphenol a 20 100 phenolic endocrine disruptor estrone 1 0.5 Natural metabolite progesterone 1 0.1 Natural female testosterone 1 0 ...

Drug Market

  • Industry report
  • May 2012
  • 3 pages
  • by Governmental Agency

... Prep- arations intended for use by man. 201.311 [Reserved] 201.312 Magnesium sulfate heptahydrate; label declaration on drug products. 201.313 estradiol labeling. 201.314 Labeling of drug ...

Endocrine, Nutritional and Metabolic Diseases Sector Analysis (endocrine, nutritional and metabolic diseases, cardiovascular disease, dermatological condition) in The United States

  • Industry report
  • June 2012
  • 57 pages

... Relative to fsh by pituitary gland Lh stimulates ovarian thecal cells to produce excessive androgen Ineffective suppression of the lh pulse frequency by estradiol and progesterone Androgen excess ...

Drug and Medication in India : Innovation and Technology Trends

  • Industry report
  • July 2013
  • 21 pages

... Rivastigmine femara letrozole femcon fe ethinylestradiol|iron|norethindrone focalin daily dexmethylphen imitrex sumatriptan keppra levetiracetam lamictal lamotrigine lipitor atorvastatin lotrel ...

The Brazilian Hormone Industry Brief

  • Industry report
  • May 2012
  • 6 pages

... Ethinylestradiol, 17 -estradiol and estriol were analyzed in urban water supply due to the concern about the problem associated with the presence of these compounds in water bodies. The aims of this project were ...

» Purchase Premium Reports (From $ 250 - $ 9 995)

14 reports for Estradiol
Richter Gedeon Nyrt. (RICHTER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Richter Gedeon Nyrt. (RICHTER) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Industry report
  • February 2014
  • by Global Data

Summary Richter Gedeon Nyrt. (Gedeon) is a pharmaceutical company. It identifies and develops manufactures and commercializes a wide range of pharmaceutical drugs, OTC medicines and medicines for the treatment ...


ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.